Press Release FDA approves Lilly’s Mounjaro (tirzepatide) to reduce cardiovascular risk in adults with type 2 diabetes Aug 28
Press Release Zepbound linked to lower healthcare costs in adults over age 55 with obesity according to a real-world study Aug 26